subscribeSubscribe
Eli Lilly`s weight-loss drug succeeds in trials with sleep apnea patients

Eli Lilly`s weight-loss drug succeeds in trials with sleep apnea patients
REUTERS
18 Apr 2024
Share Share
Tirzepatide Reduces Sleep Apnea Severity in Obese Adults

Tirzepatide Reduces Sleep Apnea Severity in Obese Adults
PR NEWSWIRE
17 Apr 2024
Share Share
Most of Lilly`s Mounjaro and Zepbound doses in limited supply, FDA says

Most of Lilly`s Mounjaro and Zepbound doses in limited supply, FDA says
REUTERS
17 Apr 2024
Share Share
Eli Lilly loses case against Florida compounding pharmacy

Eli Lilly loses case against Florida compounding pharmacy
Nicole DeFeudis ENDPTS
11 Apr 2024
Share Share
AMRA Medical Shows Tirzepatide`s Effect on Fat Biomarkers

AMRA Medical Shows Tirzepatide`s Effect on Fat Biomarkers
BUSINESSWIRE
10 Apr 2024
Share Share
Lilly`s weight-loss drug Zepbound to face supply crunch April-end, US FDA says

Lilly`s weight-loss drug Zepbound to face supply crunch April-end, US FDA says
REUTERS
03 Apr 2024
Share Share
Demand for Lilly`s Zepbound triggers US supply constraints

Demand for Lilly`s Zepbound triggers US supply constraints
Zoey Becker FIERCE PHARMA
30 Mar 2024
Share Share
Lilly drug Zepbound new US prescriptions surpass Wegovy for first time

Lilly drug Zepbound new US prescriptions surpass Wegovy for first time
REUTERS
15 Mar 2024
Share Share
Lilly partners with Amazon to deliver Zepbound and other drugs

Lilly partners with Amazon to deliver Zepbound and other drugs
REUTERS
13 Mar 2024
Share Share
CBO hints that Medicare may cover obesity drugs for cardiovascular benefits

CBO hints that Medicare may cover obesity drugs for cardiovascular benefits
Zachary Brennan ENDPTS
12 Mar 2024
Share Share